B-Cell Activity Predicts Response to Glatiramer Acetate and Interferon in Relapsing-Remitting Multiple Sclerosis.
Neurol Neuroimmunol Neuroinflamm. 2021 Mar 11;8(3):e980. doi: 10.1212/NXI.0000000000000980. Print 2021 May.
Neurol Neuroimmunol Neuroinflamm. 2021.
PMID: 33707177
Free PMC article.
Clinical Trial.